Ads
related to: brief description of multiple sclerosis disease progression in early- Treatment FAQs
See Frequently Asked
Questions. Get The Answers.
- Patient Stories
See What Real Patients
Are Saying About This Treatment.
- Financial Resources
See Financial & Savings Info.
Learn About Savings Options.
- Taking RMS Treatment
Watch A Video On How The
Treatment Is Taken.
- Relapsing MS Treatment
Learn About A RMS
Treatment Option.
- Patient Resources
Download Resources To
Learn More About Treatment.
- Treatment FAQs
Search results
Results From The WOW.Com Content Network
Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech or swallowing (), visual ...
Multiple sclerosis (MS) is an autoimmune disease resulting in damage to the insulating covers of nerve cells in the brain and spinal cord. [3] As a demyelinating disease , MS disrupts the nervous system's ability to transmit signals , resulting in a range of signs and symptoms , including physical, mental , and sometimes psychiatric problems.
Currently it is unknown what the primary cause of MS is; if MS is a heterogeneous disease, the lesion development process would not be unique. In particular, some PPMS patients having a special clinical course named rapidly progressive multiple sclerosis could have a special genetic cause [47] and a different development process.
Insidious neurological progression suggestive of MS (primary progressive MS) New criteria: One year of disease progression (retrospectively or prospectively determined) and two or three of the following: 1. Evidence for DIS in the brain based on 1 or more T2 lesions in the MS-characteristic (periventricular, juxtacortical, or infratentorial ...
In 1996, the US National MS Society (NMSS) Advisory Committee on Clinical Trials in Multiple Sclerosis, “malignant MS” was also included, namely, “disease with a rapid progressive course, leading to significant disability in multiple neurologic systems or death in a relatively short time after disease onset.” [full citation needed]
Nearly 2.3 million people are estimated to be living with multiple sclerosis around the world, but when Montel Williams received his official diagnosis back in 1999, not much was known about the ...
Ads
related to: brief description of multiple sclerosis disease progression in early